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Family-Based Association Testing of OCD-Associated SNPs
of SLC1A1 in an Autism Sample
Camille W. Brune, Soo-Jeong Kim, Gregory L. Hanna, Eric Courchesne, Catherine Lord
Bennett L. Leventhal, and Edwin H. Cook
Reports identified the neuronal glutamate transporter gene, SLC1A1 (OMIM 133550, chromosome 9p24), as a positional
and functional candidate gene for obsessive–compulsive disorder (OCD). The presence of obsessions and compulsions
similar to OCD in autism, the identification of this region in a genome-wide linkage analysis of individuals with autism
spectrum disorders (ASDs), and the hypothesized role of glutamate in ASDs make SLC1A1 a candidate gene for ASD as
well. To test for association between SLC1A1 and autism, we typed three single nucleotide polymorphisms (SNPs,
rs301430, rs301979, rs301434) previously associated with OCD in 86 strictly defined trios with autism. Family-Based
Association Tests (FBAT) with additive and recessive models were used to check for association. Additionally, an
rs301430–rs301979 haplotype identified for OCD was investigated. FBAT revealed nominally significant association
between autism and one SNP under a recessive model. The G allele of rs301979 was undertransmitted (equivalent to
overtransmission of the C allele under a dominant model) to individuals with autism (Z 52.47, P 5 0.01). The G allele
was also undertransmitted in the T–G haplotype under the recessive model (Z 52.41, P 5 0.02). Both findings were also
observed in the male-only sample. However, they did not withstand correction for multiple comparisons.
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Introduction
Autism is a neurodevelopmental disorder characterized by
deficits in reciprocal social interaction, communication,
and presence of restricted and repetitive behaviors with an
onset of symptoms by 3 years of age (Diagnostic and Statistic
Manual, DSM-IV). Twin studies indicate that autism is a
predominately genetic disorder with estimates of concor-
dance for autism being much higher among monozygotic
twins, 64–91%, than dizygotic twins and siblings, 0–9%
[Bailey et al., 1995; Bolton et al., 1994; Smalley, Asarnow, &
Spence, 1988; Steffenburg et al., 1989]. A number of
genetic variants, including copy number variants, interact
together to contribute to autism risk with common
variants at certain loci acting as ‘‘hits’’ contributing to
susceptibility to the disorder [Veenstra-VanderWeele &
Cook, 2004]. One strategy for selecting those genes that
may be candidate genes is to draw on genetic association
findings from disorders that share a phenotype similar to
autism. The heterogeneity of autism spectrum disorders
(ASDs) [for a review see Geschwind & Levitt, 2007] makes
this a difficult task, but also supports the validity of the
model, which requires more than one genetic variant to
contribute to the full syndrome of autism.
Many individuals with ASDs manifest obsessions and
compulsions similar to those seen in individuals with
obsessive–compulsive disorder (OCD) [Bodfish, Symons,
Parker, & Lewis, 2000; Leyfer et al., 2006; McDougle et al.,
1995; Russell, Mataix-Cols, Anson, & Murphy, 2005]. In
fact, some types of obsessive–compulsive behaviors, in-
cluding ordering, hoarding, touching, and tapping, occur
more often in individuals with autism than in age- and
sex-matched controls with OCD (without tics) [McDougle
et al., 1995]. These behaviors fall under the restricted and
repetitive behavior domain of autism, which includes
restricted interests, unusual preoccupations, rituals, and
insistence on sameness.
For an individual to be diagnosed with OCD, many of
these same traits are present. According to DSM-IV, the
patient must have either recurrent thoughts (obsessions)
that cause marked distress that he or she attempts to
suppress or neutralize with another thought or action, or
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repetitive behaviors or mental acts (compulsions) that the
person feels driven to perform in response to an obsession
or rules that must be applied rigidly and that are aimed at
preventing or reducing distress. The persistent thoughts
are not simply excessive worries about real-life problems.
For a diagnosis to be made, the obsessive–compulsive
symptoms must cause marked distress, take more than 1 hr
a day, or significantly interfere with the person’s daily
activities or relationships. Like autism, OCD has been
characterized as a heterogeneous disorder with three to
five symptom factors that may differ in their etiology
[Mataix-Cols, Rosario-Campos, & Leckman, 2005; Stewart
et al., 2007b]. Recently, it has been suggested that there
may be an autistic subtype of individuals with OCD who
are more resistant to treatment due to less insight into
their disorder [Bejerot, 2007]. These findings build on
previous reports of self-reported and observed autistic-like
behaviors, including social deficits, in individuals with
OCD [Bejerot, Nylander, & Lindstrom, 2001].
OCD-like traits are part of the broad autism phenotype
(i.e. a cluster of behaviors similar to those in individuals
with autism often observed in family members of autistic
individuals who lack a diagnosis), which suggests that
these behaviors may be heritable [for reviews see Bailey,
Palferman, Heavey, & Le Couteur, 1998; Murphy et al.,
2000]. Relatives of individuals with autism are more likely
than relatives of individuals with other developmental
disorders to have OCD [Bolton, Pickles, Murphy, & Rutter,
1998; Micali, Chakrabarti, & Fombonne, 2004]. Among
affected sibling pairs, two sub-domains of the Autism
Diagnostic Interview—Revised [ADI-R, Lord, Rutter, & Le
Couteur, 1994], which relate to OCD (‘‘encompassing
preoccupations/circumscribed interests’’ and ‘‘apparently
compulsive adherence to nonfunctional compulsions/
rituals’’), show strong familiality [Silverman et al., 2002].
Further, genetic studies have shown greater evidence for
linkage in families with autism with higher insistence on
sameness scores on chromosome 15q11–q13 (GABRB3)
[Shao et al., 2003], greater obsessive–compulsive behaviors
on chromosome 1 at the marker D1S1656 [Buxbaum et al.,
2004], and increased rigid–compulsive behavior at chro-
mosome 17q11.2 [Sutcliffe et al., 2005].
Recently, SLC1A1 was identified as a candidate gene for
both OCD and autism. Located on chromosome 9p24,
SLC1A1 is a neuronal glutamate transporter expressed in
the brain. This chromosomal region demonstrated sugges-
tive linkage in a genome-wide scan of seven, large
extended pedigrees of probands with early onset OCD
[Hanna et al., 2002]. This finding was replicated in 42
pedigrees with early onset OCD [Willour et al., 2004].
Subsequently, three studies have reported an association
between markers at SLC1A1 and OCD [Arnold, Sicard,
Burroughs, Richter, & Kennedy, 2006; Dickel et al., 2006;
Stewart et al., 2007a]. The Autism Genome Project, a large-
scale, collaborative autism genetics research project,
identified SLC1A1 in a genome-wide linkage scan of
autism due to its proximity to a linkage peak at 9p24.1,
and its role in glutamate function [Szatmari et al., 2007].
Both genome-wide analyses of OCD and autism detected
these findings in individuals with ‘‘narrow’’ or stricter
diagnostic criteria, and in families that contained female
probands with autism and OCD.
In addition to being a positional candidate for OCD and
autism, SLC1A1 is a functional candidate due to its role in
coding for the neuronal glutamate transporter excitatory
amino acid carrier 1. There is suggestive evidence that
glutamate plays a role in the pathology of autism
[McDougle, Erickson, Stigler, & Posey, 2005]. For example,
when compared to controls male adults with autism show
an increase in glutamate, but not other amino acids (i.e.
glutamine, glycine, D-serine, and L-serine) in serum
[Shinohe et al., 2006]. In addition, for probands with ASDs
and their first-degree relatives, increased serum glutamic
acid has also been found [Aldred, Moore, Fitzgerald, &
Waring, 2003]. Other studies have reported increased
amygdala–hippocampal glutamate in individuals with
ASDs when compared to controls using in vivo proton-
magnetic resonance spectroscopy [Page et al., 2006], and
abnormalities in the mRNA expression of members of the
glutamate system in postmortem brains of individuals with
autism [Purcell, Jeon, Zimmerman, Blue, & Pevsner, 2001].
Taken together, these reports suggest that SLC1A1 is a
viable positional and functional candidate gene for
autism, especially given the phenotypic similarities
between autism and OCD. To test whether SLC1A1 is
associated with autism, we typed three single nucleotide
polymorphisms (SNPs, rs301430, rs301979, and
rs301434) in the 30 region of the gene. The aim of the
study was to examine if previously associated SNPs in
SLC1A1 were associated with autism. Of note, these
three SNPs were associated with OCD in one or more
of the previous association studies [Arnold et al.,
2006; Dickel et al., 2006; Stewart et al., 2007a]. We tested
each marker and a previously identified haplotype
(rs301430–rs301979) for association in a strictly defined
autism sample. Because each of the previous reports
found a stronger association among male than female
probands for at least one marker tested, we also repeated
the analyses in a male-only sample. However, an alter-
native strategy would be to study SLC1A1 in autism from
a wider, less hypothesis-driven approach.
Method
Subjects and Assessment
This study was approved by the University of Illinois at
Chicago Institutional Review Board. After complete
description of the study to the parents, written informed
consent was obtained.
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Recruitment, assessment, and inclusion criteria were
the same as that outlined in a previously described
sample [Kim et al., 2002], but the sample was reduced
because only one sibling was randomly selected from
each affected sibling pair. The research participants: (1)
were at least 3 years old at the time of ADI-R adminis-
tration, (2) had sufficient blood or DNA available, and (3)
met ADI-R [Lord et al., 1994] and ADOS (Autism
Diagnostic Observational Schedule) classification for
autistic disorder [Lord et al., 2000]. In addition, all
participants had a best estimate diagnosis of autistic
disorder by a clinical psychologist and child psychiatrist.
There were 86 probands, 68 males and 18 females.
Parents identified the proband ethnicity as follows: 70
Caucasian, 5 African American, 4 Hispanic/Latino, and 7
Asian. Probands’ age at the time of the ADI-R ranged from
38 to 232 months (M 5 83, SD 5 45).
Genotyping of SNPs
Three SNPs were genotyped by TaqMans SNP genotyping
assays (Applied Biosystems, Foster City, CA) (Table IS).
The standard TaqMans SNP genotyping assay protocol
was observed for polymerase chain reactions (PCRs),
which contained 10 ng of dry DNA, 2.5 mL of 2 TaqMan
Universal Master Mix (Applied Biosystems, Foster
City, CA), 0.25 mL of 20 SNP Genotyping Assay Mix
(Applied Biosystems, Foster City, CA), and 2.25 mL of
water, for a total volume of 5 mL. All PCRs were performed
using a GeneAmps PCR System 9700 Thermocycler
(Applied Biosystems, Foster City, CA) under the following
conditions: 1 enzyme activation step at 95.01C for
10 min, and 50 alternating cycles of denaturation
at 92.01C for 15 s and reannealing and extension at
60.01C for 90 s. The fluorescence intensity of the final
reaction product was measured using a Fluoroskan Ascent
microplate fluorometer (Thermo Fisher Scientific, Inc.,
Waltham, MA).
All genotyping was performed blind to clinical and
demographic data as well as family relationships. Three
family trios were dropped from the analyses because a
sample from each trio (one parent, two probands)
repeatedly failed genotyping for all three markers. We
also identified Mendelian errors from two family trios
(one family had two Mendelian errors for both rs301434
and rs301979 and another family had a Mendelian error
for rs301434). We confirmed this finding by independent
genotyping. We suspect that the family with two errors
may have a possible deletion for at least 30 region of
SLC1A1 as the affected proband was homozygous for
rs301434 (G/G, mother G/G, father A/A), rs301979 (G/G,
mother C/G, father C/C), and rs301430 (T/T, mother C/T,
father T/T). Although it is possible that this is a case of
nonpaternity, this is inconsistent with genotypes from
this pedigree reported in other studies. The other
proband was heterozygous for rs301434; both parents
were homozygous (G/G), which is puzzling since this
family also did not have any inconsistency in genotypes
from other studies.
Statistical Analyses
The distributions of the genotypes were tested using w2
for the Hardy–Weinberg equilibrium (HWE) using the
program from the LINKUTIL package (http://linkage.
rockefeller.edu/ott/linkutil.htm). Haploview (version
4.0, http://www.broad.mit.edu/mpg/haploview/index.
php) was used to identify Mendelian errors [Barrett, Fry,
Maller, & Daly, 2005]. Single tests of association under
additive and recessive models were assessed using the
Family-Based Association Tests (FBAT) program (v. 1.7.1)
[Rabinowitz & Laird, 2000]. Recessive models were
included because they were used in at least one of the
OCD association studies [Arnold et al., 2006]; the
additive model of FBAT is presented for comparison. It
should be noted that because each SNP is biallelic, the
significance of the results for the recessive model is the
same as the dominant model (the Z-scores for the alleles
are flipped and in the opposite direction). In this study,
the FBAT empirical variance (‘‘-e’’) option was not used to
test for association in the presence of linkage because the
probands were not related (only one sibling was
randomly selected from each affected sibling pair). We
also used the ‘‘hbat’’ function in FBAT to calculate
haplotype estimations of the previously reported
rs301430–rs301979 haplotype and pairwise linkage dis-
equilibrium (LD) between the SNPs under additive,
dominant, and recessive models. The ‘‘mode a’’ option
was used to obtain test statistics for the individual
haplotypes and as a global test (www.biostat.harvard.
edu/fbat/default.html). The genotypes for the pedigrees
with Mendelian errors were set to missing for those
markers. a was set at Po0.05.
Results
Parental genotypes at each marker were consistent with
the Hardy–Weinberg equilibrium: rs301430 (w2 5 0.38,
d.f. 5 1, P 5 0.54), rs301979 (w2 5 0.52, d.f. 5 1, P 5 0.47),
and rs301434 (w2 5 1.30, P 5 0.25). Proband genotypes
were consistent with HWE for rs301430 (w2 5 0.07,
d.f. 5 1, P 5 0.79) and rs301434 (w2 5 0.01, d.f. 5 1,
P 5 0.93), but not rs301979 (w2 5 4.17, d.f. 5 1, P 5 0.04).
Table IIS shows the allele and genotype frequencies in the
parents and the probands. The lower frequency G allele
of rs301979 was undertransmitted to individuals with
autism under the FBAT recessive mode (Z 52.47,
P 5 0.01) (Table I). This is equivalent to overtransmission
of the C allele under a dominant model. The under-
transmission of the G allele was also detected in males
only under both the FBAT additive (Z 52.18, P 5 0.03)
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(equivalent to overtransmission of the C allele under the
additive model) and the recessive (Z 52.53, P 5 0.01)
models. Neither of the other SNPs showed significant
association in the full or male-only samples (Ps40.15).
LD between rs301430 and rs301979 was r2 5 0.21
(D05 1.00), between rs301430 and rs301434 was
r2 5 0.00 (D05 0.04), and between rs301979 and
rs301434 was r2 5 0.31 (D05 0.87).
Haplotype testing between rs301430 and rs301979
revealed a trend for the T/G haplotype to be under-
transmitted to probands, but only under the recessive
model (w2 5 7.41, d.f. 5 3, P 5 0.06) (Table IIIS). This was
not the case for the additive model (w2 5 3.36, d.f. 5 2,
P 5 0.19) or dominant model (w2 5 1.16, d.f. 5 3, P 5 0.76).
Because the sample size was relatively small, we also ran
haplotype permutation tests. Using this approach, the
recessive model was nominally significant (Po0.05), but
the additive (P 5 0.19) and dominant (P 5 0.90) were not.
In the male-only sample, the same trend appeared for the
T/G haplotype to be undertransmitted to probands
(Z 52.36, P 5 0.02) under the additive model (global
test: w2 5 5.68, d.f. 5 2, P 5 0.06). There were too few
observations under the recessive model to include the
T–G haplotype in the global tests. Global permutation
tests in the male-only sample approached significance
under the additive model (P 5 0.07) and was significant
under the recessive model (P 5 0.04).
Discussion
We tested three SNPs (rs301430, rs301979, rs301434) in
SLC1A1 previously identified for association with OCD
in an autism sample. One SNP (rs301979) was associated
with autism under a recessive model. The lower fre-
quency G allele was undertransmitted to individuals
with autism. This is equivalent to overtransmission
of the C allele under the dominant model. A haplotype
previously identified for association with OCD [Dickel
et al., 2006], including this SNP (rs301430–rs301979),
was also significant under a recessive model. The T–G
haplotype type was undertransmitted to individuals
with autism. These findings were found in the male-only
sample. Although there was a departure from HWE
for rs301979 in the probands, we do not think
this contributed to the association findings as the
parental genotypes did not differ from HWE.
This departure was likely due to the undertransmis-
sion of the G allele of this SNP [Wittke-Thompson,
Pluzhnikov, & Cox, 2005].
Overall, our findings are similar to the recent reports of
association between SLC1A1 and OCD in terms of
observed allele frequencies, number of informative
families, and strength of findings. Dickel et al. [2006]
reported that two of the nine SNPs they tested, including
rs3780412 from the Arnold paper (P 5 0.04) and rs301430,
which showed significant overtransmission of the C allele
(P 5 0.03), were significantly associated with OCD. Only
rs3780412 was associated with OCD when they restricted
their sample to males only. The effect of the
rs301430–rs301979 haplotype was stronger in the male-
only (P 5 0.003) than in the combined sample (P 5 0.03).
The T–C haplotype, in contrast to the T–G haplotype was
undertransmitted in these samples. In fact, the T–G
haplotype showed a trend towards overtransmission in
the male-only sample (16 transmitted vs. 7 untrans-
mitted, P 5 0.06). Stewart et al. [2007a] reported no
significant association with OCD for any single marker
when both sexes were combined (Ps40.05). However, two
other SNPs (including rs3780412) showed association in
the male-only sample (Ps 5 0.045), and a significant
3-marker haplotype including rs301430 was reported for
both the combined and male-only sample (Pso0.01).
Arnold et al. [2006] reported that three of the nine SNPs
they tested were significantly associated with OCD
including rs301434, which showed overtransmission of
the G allele under the additive and recessive models
(Pso.01). A haplotype with this marker was also
associated with OCD. These findings replicated in the
male-only sample, which also showed that the G allele of
rs301979 was marginally overtransmitted (P 5 0.07). One
limitation in comparison of the OCD studies and this
study is that the OCD studies did not report population
origin of samples.
Table I. Single Marker Associations with Autism using FBAT
SNP
Model of
inheritancea Allele Familiesb Sc E(S)d Ze Pf
rs301430 Additive C 56 43 42 0.24 0.81
Recessive C 22 8 7 0.47 0.64
T 50 21 21 0.00 1.00
rs301979 Additive C 55 78 71 1.70 0.09
Recessive C 50 24 21.75 0.66 0.51
G 18 1 5.75 2.47 0.01
rs301434 Additive A 59 65 59.5 1.27 0.20
Recessive G 37 11 14.5 1.22 0.22
A 38 17 15 0.69 0.49
Bold indicates Po0.05.
aNote for the additive model, the overtransmitted allele is shown. The
test statistic and significance level for the other allele are the same values
(Z-score in the opposite direction) because these are biallelic markers. The
corresponding Z-score and P-values for each allele of a biallelic marker
under a dominant model are the reverse of those of the recessive model
(Z-score in the opposite direction).
bNumber of informative families (i.e. families with a nonzero contribu-
tion of the test statistic).
cS, test statistics for the observed number of transmitted alleles.




FBAT, Family-Based Association Test; SNP, single nucleotide polymorphism.
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Given the trends for association in this region, one
limitation of this study is that we typed only three SNPs in
SLC1A1. Notably, we typed three of the four SNPs that
were common in the previous OCD studies. It is possible
that a susceptibility locus for autism lies within this
region that may or may not be in high LD with one of our
SNPs. This possibility may be further explored by
genotyping additional markers in this region. Future
efforts may also be directed at exploring the possible
copy number variations (CNVs) observed in one trio using
other methods, such as Quantitative PCR or Multiplex
Ligation-dependent Probe Amplification.
A second limitation of this study is the sample size,
especially with regard to the endophenotype. It would
have been ideal to select a sample in which all the
probands showed OCD-like behaviors. Half of high-
functioning individuals with autism have symptoms of
OCD [Russell et al., 2005], and OCD was the second most
prevalent (37%) co-morbid disorder in children and
adolescents with autism assessed using an adaptation of
the Kiddie Schedule for Affective Disorders and Schizo-
phrenia [Leyfer et al., 2006]. Nevertheless, it is likely that
some of our sample of individuals with autism did not
show any symptoms of OCD. In addition, the study of a
larger sample (e.g. Autism Genome Project samples)
would allow testing of possible effects of population
differences in allele frequencies or associated variants.
It is unlikely that all individuals with autism share all of
the same genetic variants. A plausible alternative is that
individuals with similar phenotypes share similar genetic
risks for the disorder. This idea is supported by behavioral
evidence that parents of individuals with autism who
score high on repetitive behaviors, as measured by the
restricted interests and compulsive behavior (D1, D2) sub-
domains on the ADI-R, have higher rates of OCD than
parents of individuals with ASDs with lower scores on
these domains [Hollander, King, Delaney, Smith, &
Silverman, 2003]. Although the ADI-R is a valid instru-
ment for diagnosing autism, it was not designed as a
rating scale and its ability to capture specific symptoms of
OCD is limited [Lord et al., 1994]. Using other measures
such as the Yale–Brown Obsessive Compulsive Scale,
which has been validated with both OCD [Scahill et al.,
1997] and autism [Scahill et al., 2006] samples, or the
Repetitive Behavior Scale—Revised [Lam & Aman, 2007],
to select individuals with high OCD symptoms may
strengthen the association between SLC1A1 and ASDs.
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